These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17397494)

  • 1. Referral compliance, outcome and predictors of CIN after repeated borderline cervical smears in the Netherlands.
    Siebers AG; Massuger LF; Bulten J
    Cytopathology; 2007 Apr; 18(2):96-104. PubMed ID: 17397494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The borderline cervical smear: colposcopic and biopsy outcome.
    al-Nafussi A; Rebello G; al-Yusif R; McGoogan E
    J Clin Pathol; 2000 Jun; 53(6):439-44. PubMed ID: 10911801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance.
    Denise Zielinski G; Snijders PJ; Rozendaal L; Voorhorst FJ; Runsink AP; de Schipper FA; Meijer CJ
    J Pathol; 2001 Oct; 195(3):300-6. PubMed ID: 11673826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance.
    ASCUS-LSIL Traige Study (ALTS) Group
    Am J Obstet Gynecol; 2003 Jun; 188(6):1383-92. PubMed ID: 12824967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test.
    Kyrgiou M; Kalliala IE; Mitra A; Fotopoulou C; Ghaem-Maghami S; Martin-Hirsch PP; Cruickshank M; Arbyn M; Paraskevaidis E
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD009836. PubMed ID: 28125861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year follow-up of women with borderline and mildly dyskaryotic cervical smears.
    Rana DN; Marshall J; Desai M; Kitchener HC; Perera DM; El Teraifi H; Persad RV
    Cytopathology; 2004 Oct; 15(5):263-70. PubMed ID: 15456414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome analysis of 4 years' follow-up of patients referred for colposcopy with one smear showing mild dyskaryosis.
    Ahmed AS; Goumalatsos G; Akbar N; Lawton FG; Savvas M
    Cytopathology; 2008 Apr; 19(2):94-105. PubMed ID: 17937774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations.
    ASCUS-LSIL Traige Study (ALTS) Group
    Am J Obstet Gynecol; 2003 Jun; 188(6):1393-400. PubMed ID: 12824968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.
    Ciotti M; Sesti F; Paba P; Benedetto A; Patrizi L; Criscuolo A; Piccione E; Branca M; Syrjänen K; Favalli C
    Eur J Gynaecol Oncol; 2004; 25(5):577-84. PubMed ID: 15493169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program.
    Loopik DL; Koenjer LM; Siebers AG; Melchers WJG; Bekkers RLM
    Am J Obstet Gynecol; 2021 Feb; 224(2):200.e1-200.e9. PubMed ID: 32800820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of two strategies to follow-up ASC-US and LSIL screening results in The Netherlands using repeat cytology with or without additional hrHPV testing: a retrospective cohort study.
    Siebers AG; Arbyn M; Melchers WJ; van Kemenade FJ; Vedder JE; van der Linden H; van Ballegooijen M; Bekkers RL; Bulten J
    Cancer Causes Control; 2014 Sep; 25(9):1141-9. PubMed ID: 24935226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of high-grade cervical intraepithelial neoplasia among young women with abnormal screening cytology.
    Massad SL; Markwell S; Cejtin HE; Collins Y
    J Low Genit Tract Dis; 2005 Oct; 9(4):225-9. PubMed ID: 16205193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
    Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A
    J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing atypical squamous cells of undetermined significance in Papanicolaou smears.
    Morin C; Bairati I; Bouchard C; Fortier M; Roy M; Moore L; Meisels A
    J Reprod Med; 2001 Sep; 46(9):799-805. PubMed ID: 11584480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996.
    Bulk S; Van Kemenade FJ; Rozendaal L; Meijer CJ
    J Clin Pathol; 2004 Apr; 57(4):388-93. PubMed ID: 15047743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus and predictors of cervical intraepithelial neoplasia among young mothers in a prospective follow-up study.
    Louvanto K; Syrjänen KJ; Rintala MA; Grénman SE; Syrjänen SM
    Acta Obstet Gynecol Scand; 2011 Feb; 90(2):167-73. PubMed ID: 21241262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Wait-and-see policy versus loop excision after two consecutive Pap-2 cervical smears: over time less surgery and an equivalent outcome; no substantial contribution to be expected from the detection of high risk human papillomavirus].
    Bekkers RL; Hanselaar AG; Melchers WJ; van Schaik JH; Boonstra H; Massuger LF
    Ned Tijdschr Geneeskd; 2003 Feb; 147(7):302-6. PubMed ID: 12622008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline human papillomavirus status of women with abnormal smears in cervical screening: a 5-year follow-up study in The Netherlands.
    Prinsen CF; Fles R; Wijnen-Dubbers CW; de Valk HA; Klaassen CH; Mravunac M; Horrevorts AM; Thunnissen FB
    BJOG; 2007 Aug; 114(8):951-7. PubMed ID: 17578475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanded cytological referral criteria for colposcopy in cervical screening: comparison with human papillomavirus testing.
    Paraskevaidis E; Malamou-Mitsi V; Koliopoulos G; Pappa L; Lolis E; Georgiou I; Agnantis NJ
    Gynecol Oncol; 2001 Aug; 82(2):355-9. PubMed ID: 11531293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The natural history of cervical intraepithelial neoplasia I and the clinical significance of p16(INK4a) protein as a marker of progression in cervical intraepithelial neoplasia I].
    Wang R; Li X; Qian M; Niu J; You Z
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):210-5. PubMed ID: 26268412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.